Search results
Q1 2024 Syros Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 11 hours agoWe are very encouraged by recent progress of our programs in high-risk MDS and unfit AML. As David will discuss shortly, our Phase 3 SELECT-MDS-1 trial ...
Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
WKRN Nashville· 11 hours agoAs of May 9, 2024, Ryvu's cash position was $59.0M, inclusive of the first tranche of €8M in venture debt from the EIB, obtained in March. This cash position, and other secured funding sources ...
Syros Pharmaceuticals Inc (SYRS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 10 hours agoPositive Points Syros Pharmaceuticals Inc (NASDAQ:SYRS) reported passing the prespecified interim futility analysis for the Phase 3 SELECT-MDS-1 trial, indicating continued ...
The Keto Diet Explained: Is the Popular Weight Loss Regimen Effective?
Woman's World via Yahoo News· 5 hours agoIn the last decade or so, the Ketogenic — or "keto diet" — has garnered tremendous popularity among...
Ryvu Therapeutics to present clinical and preclinical data on RVU120 at the 2024 European Hematology...
FOX 23 News Albany· 1 day agoUpdated data from the Phase I trial of RVU120 in patients with relapsed/refractory acute myeloid...
What are myelodysplastic syndromes (MDS)?
MedicineNet.com· 5 days agoA myelodysplastic syndrome (MDS) is a type of blood cancer in which the blood-forming cells of the spongy part of the bone become abnormal.
Here’s How To Tell if Your Toenail Fungus Is Dying + 3 Natural Remedies To Speed Healing
Woman's World via Yahoo News· 2 days agoWe asked Dr. Straight and other MDs to explain once and for all what toenail fungus is, how to know...
Promising Combination Therapy for Triple Negative Breast Cancer Treatment: A Milestone Collaboration...
NewMediaWire via Yahoo Finance· 3 hours agoFREMONT, CA - (NewMediaWire) - May 15, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 20 hours ago– Observed encouraging complete response (CR) rates as of the February 1, 2024, data cutoff in previously untreated HR-MDS and TP53m AML patients; successfully bridged responding ...
Study: Older Adults With Aggressive Blood Cancer A | Newswise
Newswise· 5 days agoStandard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over...